Astellas Pharma Inc. ADR (ALPMY): Price and Financial Metrics
GET POWR RATINGS... FREE!
ALPMY Stock Price Chart Interactive Chart >
ALPMY Price/Volume Stats
| Current price | $16.42 | 52-week high | $18.46 |
| Prev. close | $16.55 | 52-week low | $13.41 |
| Day low | $16.27 | Volume | 37,600 |
| Day high | $16.48 | Avg. volume | 69,802 |
| 50-day MA | $17.17 | Dividend yield | 1.7% |
| 200-day MA | $15.92 | Market Cap | 30.57B |
Astellas Pharma Inc. ADR (ALPMY) Company Bio
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
ALPMY Price Returns
| 1-mo | -4.76% |
| 3-mo | 8.20% |
| 6-mo | -0.82% |
| 1-year | 3.13% |
| 3-year | 6.02% |
| 5-year | 0.14% |
| YTD | 7.27% |
| 2020 | -7.64% |
| 2019 | 37.34% |
| 2018 | 0.64% |
| 2017 | -8.51% |
| 2016 | -3.14% |
ALPMY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...